A groundbreaking shift in Canadian drug policy has taken place, as the authorities allow the legalization of psilocybin hallucinogens for therapeutic purposes. Previously, these substances were strictly restricted, but a growing body of research suggests they could offer benefits for psychological issues like depression. This change represents a ke